From: Frequency and clinical implications of the isolation of rare nontuberculous mycobacteria
Demographics | N (%) |
Age (year), median (range) | 68.0 (30.0–84.0) |
Sex (Male) | 39/68 (57.4) |
Body Mass Index (kg/m2), median (range) | 22.4 (15.9–29.0) |
Habitual factors | N (%) |
Smoking | 19/68 (33.8) |
Ex-smoker | 13/68 (22.4) |
Current smoker | 6/68 (10.3) |
Past medical history | N (%) |
Previous history of TB | 24/68 (35.3) |
Sinusitis | 9/68 (13.2) |
Measles | 3/68 (4.4) |
Pertussis | 1/68 (1.5) |
Comorbidities | N (%) |
Malignancies | 7/68 (10.3) |
Lung cancer | 1/68 (1.5) |
Diabetes | 6/68 (8.8) |
Cerebrovascular disease | 2/68 (2.9) |
Rheumatoid arthritis | 3/68 (4.4) |
Inflammatory bowel disease | 0/68 (−) |
Gastroesophageal reflux | 0/68 (−) |
Underlying lung disease | |
COPD | 4/68 (5.9) |
Asthma | 4/68 (5.9) |
TB-destroyed lung | 3/68 (4.4) |
Interstitial lung disease | 1/68 (1.5) |
Bronchiectasis | 23/68 (33.8) |
HIV infection | 1/68 (1.5) |
Post-transplantation status | 0/68 (−) |
Symptoms | N (%) |
Cough | 30/68 (44.1) |
Dyspnea | 13/68 (19.1) |
Hemoptysis | 11/68 (16.2) |
Sputum | 39/68 (57.4) |
Fever | 6/68 (8.8) |
Myalgia | 4/68 (5.9) |
Weight loss | 6/68 (8.8) |
Physical examination | N (%) |
Postnasal drip | 10/68 (14.7) |
Crackle | 4/68 (5.8) |
Wheezing | 1/68 (1.5) |
Murmur | 0/68 (−) |
Clubbing | 0/68 (−) |
Peripheral edema | 0/68 (−) |
Drug use | |
TNF-alpha inhibitor* | 1/68 (1.5) |
Steroid (5–10 mg daily)* | 3/68 (4.4) |
Other immunomodulatory drugs* | 2/68 (2.9) |